InvestorsHub Logo
Followers 33
Posts 2436
Boards Moderated 0
Alias Born 03/02/2019

Re: sts66 post# 310361

Wednesday, 11/18/2020 5:30:11 PM

Wednesday, November 18, 2020 5:30:11 PM

Post# of 426504
V is a unique drug with carve out being brought into existence in its early patent life. This is unique. Not like a statin having patent expire and generics come in. Much more like carcedilol and the GSK-TEVA case. When the generics infringe on the REDUCIT population and the intact REDUCIT patents...all hell will break loose.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News